Search Tag: Seraph 10

ICU Management

Michael Porter Of Harvard Business School Has Joined The Board Of Directors Of Exthera Medical

2020 29 Sep

Michael Porter, Ph.D., has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company focused on the therapeutic reduction of drug-resistant pathogens and sepsis mediators in whole blood. ExThera’s  Seraph® 100 Microbind® Affinity Blood Filter  (Seraph 100) has a CE Mark in Europe for the treatment... Read more